ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Hot Features

Registration Strip Icon for charts Regístrate para obtener gráficos en tiempo real, herramientas de análisis y precios.
Vanguard Large Cap ETF

Vanguard Large Cap ETF (VV)

272.70
3.40
(1.26%)
Cerrado 05 Enero 3:00PM
272.78
0.08
(0.03%)
Fuera de horario: 6:59PM

Mejore su cartera: debates en tiempo real e ideas comerciales prácticas.

Estadísticas y detalles clave

Último Precio
272.70
Postura de Compra
-
Postura de Venta
-
Volume Operado de la Acción
242,784
270.16 Rango del Día 272.9699
214.24 Rango de 52 semanas 280.79
Capitalización de Mercado [m]
Precio Anterior
269.30
Precio de Apertura
270.54
Última hora de negociación
Volumen financiero
US$ 66,041,171
Precio Promedio Ponderado
272.0162
Volumen promedio (3 m)
232,605
Acciones en circulación
140,730,000
Rendimiento del Dividendo
-
Ratio Precio/Utilidad
3.94
Beneficio por acción (BPA)
69.16
turnover
649.37M
Beneficio neto
9.73B

Acerca de Vanguard Large Cap ETF

The investment seeks to track the performance of the CRSP US Large Cap Index that measures the investment return of large-capitalization stocks. The fund employs an indexing investment approach designed to track the performance of the CRSP US Large Cap Index, a broadly diversified index of large U.S... The investment seeks to track the performance of the CRSP US Large Cap Index that measures the investment return of large-capitalization stocks. The fund employs an indexing investment approach designed to track the performance of the CRSP US Large Cap Index, a broadly diversified index of large U.S. companies representing approximately the top 85% of the U.S. market capitalization. The advisor attempts to replicate the target index by investing all, or substantially all, of its assets in the stocks that make up the index, holding each stock in approximately the same proportion as its weighting in the index. Mostrar más

Sector
Mgmt Invt Offices, Open-end
Industria
Mgmt Invt Offices, Open-end
Sitio web
Sede
Valley Forge, Pennsylvania, USA
Fundado
-
Vanguard Large Cap ETF is listed in the Mgmt Invt Offices, Open-end sector of the American Stock Exchange with ticker VV. The last closing price for Vanguard Large Cap ETF was US$269.30. Over the last year, Vanguard Large Cap ETF shares have traded in a share price range of US$ 214.24 to US$ 280.79.

Vanguard Large Cap ETF currently has 140,730,000 shares in issue. The market capitalisation of Vanguard Large Cap ETF is US$37.90 billion. Vanguard Large Cap ETF has a price to earnings ratio (PE ratio) of 3.94.

VV Últimas noticias

No news to show yet.
Período †Variación(Ptos)Variación %AperturaPrecio MáximoPrecio MínimoAvg. Vol. diarioPrecio Promedio Ponderado
1-2.67-0.969604532084275.37275.37267.5265000270.8612625SP
4-7.4-2.64191360228280.1280.79267.5234106274.8512522SP
128.323.1469853998264.38280.79260.875232605271.4039307SP
2620.658.19281888514252.05280.79233.4220295262.02621414SP
5256.6726.2324677128216.03280.79214.24228700247.55716111SP
15651.4823.2709519935221.22280.79159.02322339201.89279831SP
260125.1384.7936572474147.57280.79100.5332008184.88546139SP

Movimientos

Ver todo
  • Volumen
  • % Mayores Alzas
  • % Mayores Bajas
SímboloPrecioVol.
FCUVFocus Universal Inc
US$ 0.9499
(174.93%)
260.93M
NITON2OFF Inc
US$ 2.6306
(145.85%)
358.28M
CRNCCerence Inc
US$ 19.33
(143.76%)
161.8M
KITTNauticus Robotics Inc
US$ 3.8249
(140.56%)
104.8M
ACONAclarion Inc
US$ 0.2984
(110.14%)
305.64M
HWHHWH International Inc
US$ 0.4621
(-28.80%)
7.43M
SMSTDefiance Daily Target 2x Short MSTR ETF
US$ 5.69
(-26.30%)
24.77M
RAINRain Enhancement Technologies Holdco Inc
US$ 5.59
(-23.42%)
161.15k
PTLEPTL Ltd
US$ 9.35
(-23.30%)
1.04M
NXUNXU Inc
US$ 0.725868
(-22.78%)
7.59M
NITON2OFF Inc
US$ 2.6306
(145.85%)
358.28M
TGLTreasure Global Inc
US$ 0.382
(101.58%)
337.5M
ACONAclarion Inc
US$ 0.2984
(110.14%)
305.64M
FCUVFocus Universal Inc
US$ 0.9499
(174.93%)
260.93M
NVDANVIDIA Corporation
US$ 144.47
(4.45%)
230.01M
eagle8 eagle8 7 minutos hace
Peter Davis
@peter_brit
#dcvax $nwbo #gbm

FDA Signals potential for standard approval of Paxalisib in Glioblastoma - AI Analysis (Gemini) of possible implications for FDA approval of #dcvax

The FDA's decision regarding paxalisib in glioblastoma (GBM) pro
NWBO
Iggy_Bot Iggy_Bot 9 minutos hace
Im so happy dems are doing stuff like this, Nevada should be red for a long time now
and between the people of the state and Trump i would bet it will be over turned,
ElectricMountain53 ElectricMountain53 17 minutos hace
What Lebby said has got no value anymore. He also said deals were around the corner and many other things that haven´t come to fruition. Now he´s fired.
Let´s just wait what Yves has to say next week!!
You posting so much seems like pumping before the 9th!
Are you afraid of wh
LWLG
igotthemojo igotthemojo 40 minutos hace
i am speaking as the foremost authority on kblb that there is...bar none...i am saying that this stock is ready to fly...and will start flying BEFORE Feb...i have spoken...
KBLB
nowwhat2 nowwhat2 43 minutos hace
The Total 3

https://investorshub.advfn.com/uimage/uploads/2025/1/5/twljxtotal_3_!_5_5d_1212am_whump.jpg



Sho nuff.......Whump......Much of this is XRP but I'll betcya Doge, etc. SOL, too

https://investorshub.advfn.com/uimage/uploads/2025/1/
XRPUSD
boi568 boi568 51 minutos hace
That spike to $31.50 was not organic and it was clearly generated by a big player. I have always thought it was an engineered mini-short squeeze.
AVXL
Mr. Bill Mr. Bill 1 hora hace
https://www.goodrx.com/well-being/sleep/how-to-sleep-with-sciatica
nowwhat2 nowwhat2 1 hora hace
Could still just be climbing in sympathy w overall crypto mkt

Scathingly poor outlooks

https://www.youtube.com/watch?v=EOsjnOUAw14



https://investorshub.advfn.com/uimage/uploads/2025/1/5/siwcoTOTAL_3_!_4_3M_JUNCT_DAY_1.jpg

WONDF
DonVance DonVance 1 hora hace
This will hit 1k this year I believe now.
MSTR
georgejjl georgejjl 1 hora hace
How many of the 7 million Alzheimer’s patients in the USA are projected to be treated with the MAB infusions during 2025???

How many people with Alzheimer’s in the USA are projected to be treated with donepezil (Aricept) or memantine during 2025???

The treatment used t
AVXL
Mr. Bill Mr. Bill 1 hora hace
Stretches https://www.healthline.com/health/back-pain/sciatic-stretches#sitting-spinal-stretch
Graniteguy Graniteguy 1 hora hace
Doc and Investor posters here tend to be negatively biased which you whole heartedly champion, especially "Doc" who's medical opinion is at best questionable, and incredibly biased, to fit a narrative of constant failure for Anavex's Blarcamesine. The fact that you pile onto their "steaming pile of
AVXL
BDEZ BDEZ 1 hora hace
The Russes hit the jackpot?
BDEZ BDEZ 1 hora hace
40% of homicides in the US take place in districts with a Soros-funded prosecutor.

Biden gave him a Medal Of Freedom.

https://x.com/EndWokeness/status/1875725808071012529
BDEZ BDEZ 1 hora hace
Not good, thanks for sharing.
sand sand 1 hora hace
Thank you Ducci for all your sharing and insights extremely helpful. I'm slowly diligently getting there rewiring the brain and focusing on what shows the moves. Much continued success this week. Thank you again.
SPY
mining101 mining101 1 hora hace
Moving hard soon 
EFSH
mining101 mining101 1 hora hace
Superb
MEGL
benz280c benz280c 1 hora hace
Speak louder and maybe you will convince somebody that this is how you really feel. No need to be insecure around your fellow investors.
GDVM
rx7171 rx7171 2 horas hace
In addition MABs are approved for only a limited portion of the AD population, whereas Blarcamasine appears to be effective in 70-80% of the ITT population with its strongest efficacy in the 70% with wild type Sigma-1.
AVXL
TheHound TheHound 2 horas hace
Learn how to use the bull market support band with that chart and you’ll have a powerful tool under your belt!
XRPUSD
Investor2014 Investor2014 2 horas hace
When I say that the totality of information is what Anavex rely on it does take into account the pretty ineffective SOC, associated risks and inconveniences for patients.

Still any drug regulatory process must and should look carefully at the data to ensure that neither type one or tw
AVXL